Supervisory Board - 监事会

Dr. Stefan Elsser

Chairman

Dr. Stefan Elsser has been Partner at BBP Elsser Ruof & Partner in Stuttgart since 2008. BBP is a professional advisory company for Private Equity and Venture Capital Investors and well-respected family offices. Before joining BBP, Dr. Elsser held various senior management and professional positions at 3i Deutschland and at Technologieholding VC GmbH, as well as at KfW, the German federal development bank.

He brings more than 20 years of experience in all aspects of corporate finance, along with a broad knowledge in portfolio monitoring – including several investments in the fields of MedTech, Lifescience and Nanotechnology.

Dr. Elsser studied economics at the Karl Eberhard University in Tübingen, Germany, and at the University of Oregon in Eugene. In 1993 he received his doctoral degree with honours from the University of Hohenheim in Stuttgart.

Dr. Simon Nebel

Vice Chairman

Simon Nebel is Managing Partner of Aravis and has its own consultancy company Viopas Venture Consulting. He has participated in investing, managing and divesting in a number of life science companies of Aravis portfolio. Simon has been board member or observer in thirteen companies and is currently a board member of SynAffix (NL), MarinoMed (AT), Bird Rock Bio (La Jolla/USA)).

Before joining Aravis, Simon was a group strategist at UBS (London, Basel and Zurich), where he coordinated and worked on business planning and modelling. This included developing a Biotechnology Venture Capital business proposal for UBS Capital.

Simon holds a PhD in Biophysics from the Biocentre of the University of Basel (1996) and an MBA with distinction from the London Business School (2001).

Dr. Bernd Hartmann

Board Member

Dr. Hartmann began his professional career in the management of the Berlin branch of Allianz. Thereafter, he continued at Roskos & Meier OHG and is general partner. He is responsible for public relations, company and private pension schemes as well as liability insurances.

Dr. Hartmann provides specific expertise in the fields of regenerative energy, in particular photovoltaics. Dr. Hartmann is engaged in social activities such as the Kinderhilfsfond der Allianz and the Kulturstiftung Allianz.

史蒂芬 ·艾尔萨博士

主席

史蒂芬 ·艾尔萨博士自2008年以来一直是斯图加特BBP Elsser Ruof&Partner的合伙人。BBP是一家以私募股权和风险投资公司以及家庭办公室为主要对象的专业咨询公司。 在加入BBP之前,艾尔萨博士在德国3i公司和Technologieholding VC公司以及德国联邦开发银行KfW担任过各种高级管理职位。

他在公司理财的各个方面拥有超过20年的经验,在投资组合监控方面拥有丰富的知识,其中包括在医疗器械、生命科学以及纳米技术领域的多项投资。

艾尔萨博士曾在德国图宾根的Karl Eberhard大学和美国Oregon大学主修经济学。 1993年,他在斯图加特的Hohenheim大学荣获博士学位。

西蒙·内贝尔博士

副主席

西蒙·内贝尔博士是Aravis公司的执行合伙人,并拥有自己的咨询公司Viopas Venture Consulting。 他参与了多家生命科学公司的投资、管理和撤资项目。 西蒙担任过13家公司的董事会成员、董事会观察员,目前是SynAffix(荷兰),MarinoMed(奥地利),Bird Rock Bio(拉霍亚/ 美国))的董事会成员。

在加入Aravis之前,西蒙是UBS瑞银(伦敦,巴塞尔和苏黎世)的集团策略师。他的职责是协调和从事商业规划和业务建模,也包括为瑞银资本开发生物技术创业投资类商务计划。

西蒙在1996年获得瑞士巴塞尔大学生物中心的生物物理学博士学位,并在2001年以优异成绩获得伦敦商学院的MBA学位 。

 

伯德·哈特曼博士

监事会成员

哈特曼博士在安联保险的柏林分公司管理层开始了他的职业生涯。继安联之后他成为RoskosMeier OHG的合伙人。他主要负责公共关系、公司和私人养老金计划以及责任保险。

哈特曼博士是再生能源,尤其是光伏发电领域的专家。此外,他还广泛地从事社会活动,如安联儿童救济基金以及安联文化基金会等。